Arkolith/Insider Trading/ARCT/Form 4

Kummerfeld Keith C

See RemarksArcturus Therapeutics Holdings Inc. (ARCT) · full profile →Form 4 · filed Apr 19, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$196K
Net Open-Market Flow
-$196K
Transactions
7
4 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 18, 2023Option exercise(M)5K$9.04$41K6K
Apr 18, 2023Option exercise(M)1K$4.99$7K8K
Apr 18, 2023Sell(S)7K$28.18$196K950
Apr 18, 2023Option exercise(M)1K$14.12$15K2K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 17, 2023Option exercise(M)5K—$026K
Apr 17, 2023Option exercise(M)1K—$09K
Apr 17, 2023Option exercise(M)1K—$09K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193805-23-000578) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML